![3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Structure](https://www.chemicalbook.com/CAS/20200515/GIF/2097982-05-1.gif)
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
- Product Name3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-
- CAS2097982-05-1
- CBNumberCB15909561
- MFC13 H19 N5
- MW245.32
- MOL File2097982-05-1.mol
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Price
| Product number | Packaging | Price | Product description | Buy |
|---|---|---|---|---|
| Biosynth XID98205 | 100mg | $250 | Tofacitinib impurity 3 |
Buy |
| Biosynth XID98205 | 250mg | $267.5 | Tofacitinib impurity 3 |
Buy |
| Biosynth XID98205 | 500mg | $430 | Tofacitinib impurity 3 |
Buy |
| Biosynth XID98205 | 1000mg | $680 | Tofacitinib impurity 3 |
Buy |
| Biosynth XID98205 | 5000mg | $2200 | Tofacitinib impurity 3 |
Buy |
Preparation Products And Raw materials
3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- Suppliers
Global(11)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 021-20242659 18930833303 |
sales@changyanchem.cn | China | 4998 | 55 | |
| 13268215580 | scinova_sales@163.com | China | 7011 | 58 | |
| 18126517264 | 2850476883@qq.com | China | 7948 | 58 | |
| 18627753421; 18627756402 |
3001051413@qq.com | China | 20010 | 58 | |
| +86-13424074264; 13726739909 |
chenhuini@cti-cert.com | China | 497 | 58 | |
| 18457506494 | 3779628498@qq.com | China | 8573 | 58 | |
| chuanxupharma@126.co | chuanxupharma@126.com | China | 9953 | 58 | |
| +86-18603013401 | jack.lin@sincopharmachem.com | China | 9999 | 58 | |
| +86-18627948422 | sale@hdimpurity.com | China | 3676 | 58 |
View Latest Prices from 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)- manufacturers
2097982-05-1, 3-Piperidinamine, N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3R,4R)-Related Search
- 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
- (3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
- 3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyriMidin-4-yl)(Methyl)aMino)-4-Methylpiperidin-1-yl)-3-oxopropanenitrile
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanoic acid
- Carbamic acid, [(3R,4R)-4-methyl-3-piperidinyl]-, 1,1-dimethylethyl ester (9CI)
- (3S,4S)-Tofacitinib
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- 3-Piperidinamine, 1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethyl-, (3R,4R)-
- N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
1of4
PROMPT×
PROMPT
The WhatsApp is temporarily not supported in mainland China
The WhatsApp is temporarily not supported in mainland China
Cancel
Determine